This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Willis Towers (WTW) Q2 Earnings Miss, Revenues Beat Estimates
by Zacks Equity Research
Willis Towers (WTW) Q2 results reflect the solid performance of the Health, Wealth & Career and Risk & Broking segments, which was offset by higher expenses.
Arthur J. Gallagher (AJG) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Arthur J. Gallagher (AJG) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Arthur J. Gallagher (AJG) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Arthur J. Gallagher (AJG) delivered earnings and revenue surprises of 2.15% and 2.41%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks' Q2 Earnings Due on Jul 27: AJG, CINF & More
by Sushmita Sarker
Strong retention, new business, reinsurance agreements, interest rate hikes and technological advancement are likely to drive second-quarter results of insurers like AJG, CINF, WTW, AMSF and FAF.
What's in Store for Arthur J. Gallagher (AJG) in Q2 Earnings?
by Zacks Equity Research
Arthur J. Gallagher's (AJG) second-quarter results are likely to reflect new business, strong retention and renewal premium increases, and an improvement in interest income, offset by higher expenses.
Aon (AON) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Aon (AON) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arthur J. Gallagher (AJG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Arthur J. Gallagher (AJG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arthur J. Gallagher (AJG) Boosts Insurance Business With Buyout
by Zacks Equity Research
Arthur J. Gallagher (AJG) acquires Benchmark to enhance its existing growth opportunities in Southern California.
Marsh & McLennan (MMC) Unit Expands in the Healthcare Industry
by Zacks Equity Research
Marsh & McLennan Companies' (MMC) subsidiary strengthens its position in the healthcare industry through the acquisition of Trideo Systems.
Arthur J. Gallagher (AJG) Up 14% YTD: Will the Bull Run Last?
by Zacks Equity Research
Solid performance of the Brokerage and Risk Management segments, strategic buyouts to capitalize on growing market opportunities and effective capital deployment poise Arthur J. Gallagher (AJG) for growth.
Should iShares Morningstar Mid-Cap Growth ETF (IMCG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IMCG
Top Analyst Reports for BHP Group, AstraZeneca & Boeing
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including BHP Group Limited (BHP), AstraZeneca PLC (AZN) and The Boeing Company (BA).
Arthur J. Gallagher (AJG) Expands With Strategic Acquisitions
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of The Andersen Group and Fender Marine AS strengthens its position as a leading global insurance brokerage and risk management firm.
American Financial (AFG) Closes Crop Risk Services Buyout
by Zacks Equity Research
American Financial's (AFG) Great American Insurance Group strengthens its position in the crop insurance market with the acquisition of Crop Risk Services.
Is SPDR S&P Insurance ETF (KIE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for KIE
Should Vanguard Mid-Cap Value ETF (VOE) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VOE
Arthur J. Gallagher (AJG) Shares Up 31% YTD: More Upside Left?
by Zacks Equity Research
Solid performance of the Brokerage and Risk Management segments, strategic buyouts to capitalize on growing market opportunities and effective capital deployment continue to drive Arthur J. Gallagher (AJG).
Should You Invest in the SPDR S&P Insurance ETF (KIE)?
by Zacks Equity Research
Sector ETF report for KIE
Arthur J. Gallagher (AJG) Expands Brokerage Business With Buyout
by Zacks Equity Research
Arthur J. Gallagher (AJG) boosts its brokerage and consulting business with Bernard Benefits and Bernard Healthcare Financial Planning acquisition.
Arthur J. Gallagher (AJG) Boosts Capabilities With IBKB Buyout
by Zacks Equity Research
Arthur J. Gallagher's (AJG) Insurance by Ken Brown acquisition will help consolidate its presence in Florida and Southeast United States.
Brown & Brown (BRO) to Expand UK Presence With Buyout
by Zacks Equity Research
Brown & Brown's (BRO) pending Kentro Capital Limited acquisition will help it boost presence London.
Arthur J. Gallagher (AJG) on a Buyout Spree, Boosts Portfolio
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyouts help it solidify geographical presence as well as consolidate portfolio.
Brown & Brown (BRO) Acquires Brownlee Agency, Boosts Portfolio
by Zacks Equity Research
Brown & Brown's (BRO) buyout of Brownlee Agency is likely to strengthen the insurance broker's capabilities and expand its presence in Georgia.
Should iShares Morningstar Mid-Cap Growth ETF (IMCG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IMCG
Arthur J. Gallagher (AJG) Q1 Earnings Top on Margin Expansion
by Zacks Equity Research
Arthur J. Gallagher's (AJG) Q1 results reflect strong Brokerage and Risk Management segments, pricing increases and consistent primary insurance market conditions.